NicOx collaboration first casualty of Topigen acquisition
This article was originally published in Scrip
Executive Summary
NicOx and Topigen Pharmaceuticals' collaboration over TPI 1020 has become a casualty of Topigen's acquisition by Pharmaxis (scripnews.com, January 12th, 2010).